180 related articles for article (PubMed ID: 31849461)
1. Serum Alpha-1 Antitrypsin Levels and the Clinical Course of Chronic Obstructive Pulmonary Disease.
Takei N; Suzuki M; Makita H; Konno S; Shimizu K; Kimura H; Kimura H; Nishimura M
Int J Chron Obstruct Pulmon Dis; 2019; 14():2885-2893. PubMed ID: 31849461
[TBL] [Abstract][Full Text] [Related]
2. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV
Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R
Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839
[TBL] [Abstract][Full Text] [Related]
3. SERPINA1 11478G→A variant, serum α1-antitrypsin, exacerbation frequency and FEV1 decline in COPD.
Quint JK; Donaldson GC; Kumari M; Talmud PJ; Hurst JR
Thorax; 2011 May; 66(5):418-24. PubMed ID: 21335450
[TBL] [Abstract][Full Text] [Related]
4. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
Stockley RA; Edgar RG; Pillai A; Turner AM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of alpha-1-antitrypsin levels in blood serum of patients with chronic obstructive pulmonary disease.
Perincek G; Avcı S
Acta Biomed; 2018 Oct; 90(1):37-43. PubMed ID: 30889153
[TBL] [Abstract][Full Text] [Related]
6. Decline in FEV
Hiller AM; Piitulainen E; Jehpsson L; Tanash H
Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
[No Abstract] [Full Text] [Related]
7. Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease.
Ghosh AJ; Hobbs BD; Moll M; Saferali A; Boueiz A; Yun JH; Sciurba F; Barwick L; Limper AH; Flaherty K; Criner G; Brown KK; Wise R; Martinez FJ; Lomas D; Castaldi PJ; Carey VJ; DeMeo DL; Cho MH; Silverman EK; Hersh CP;
Am J Respir Crit Care Med; 2022 Feb; 205(3):313-323. PubMed ID: 34762809
[No Abstract] [Full Text] [Related]
8. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.
Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R;
Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
Rahaghi FF; Miravitlles M
Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
[TBL] [Abstract][Full Text] [Related]
10. Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease.
Suzuki M; Makita H; Östling J; Thomsen LH; Konno S; Nagai K; Shimizu K; Pedersen JH; Ashraf H; Bruijnzeel PL; Maciewicz RA; Nishimura M; ;
Ann Am Thorac Soc; 2014 Dec; 11(10):1511-9. PubMed ID: 25372271
[TBL] [Abstract][Full Text] [Related]
11. Interrelationship between serum and sputum inflammatory mediators in chronic obstructive pulmonary disease.
Bizeto L; Mazzolini AB; Ribeiro M; Stelmach R; Cukier A; Nunes MP
Braz J Med Biol Res; 2008 Mar; 41(3):193-8. PubMed ID: 18327434
[TBL] [Abstract][Full Text] [Related]
12. Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS Cohort.
Burkes RM; Ceppe AS; Doerschuk CM; Couper D; Hoffman EA; Comellas AP; Barr RG; Krishnan JA; Cooper C; Labaki WW; Ortega VE; Wells JM; Criner GJ; Woodruff PG; Bowler RP; Pirozzi CS; Hansel NN; Wise RA; Brown TT; Drummond MB;
Chest; 2020 Apr; 157(4):856-865. PubMed ID: 31958447
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Small Airways in Patients with Chronic Obstructive Pulmonary Disease and Alpha-1 Antitrypsin Deficiency.
Ferrari da Cruz T; Rufino R; Lopes AJ; Noronha A; Medeiros Anselmo F; Henrique da Costa C
Int J Chron Obstruct Pulmon Dis; 2020; 15():2267-2274. PubMed ID: 33061344
[TBL] [Abstract][Full Text] [Related]
14. Oxidized Alpha-1-Antitrypsin as a Potential Biomarker Associated with Onset and Severity of Chronic Obstructive Pulmonary Disease in Adult Population.
Topic A; Milovanovic V; Lazic Z; Ivosevic A; Radojkovic D
COPD; 2018 Oct; 15(5):472-478. PubMed ID: 30822244
[TBL] [Abstract][Full Text] [Related]
15. Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study.
Calle Rubio M; Soriano JB; López-Campos JL; Soler-Cataluña JJ; Alcázar Navarrete B; Rodríguez González-Moro JM; Miravitlles M; Barrecheguren M; Fuentes Ferrer ME; Rodriguez Hermosa JL;
PLoS One; 2018; 13(6):e0198777. PubMed ID: 29953442
[TBL] [Abstract][Full Text] [Related]
16. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population.
Dahl M; Tybjaerg-Hansen A; Lange P; Vestbo J; Nordestgaard BG
Ann Intern Med; 2002 Feb; 136(4):270-9. PubMed ID: 11848724
[TBL] [Abstract][Full Text] [Related]
17. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
[TBL] [Abstract][Full Text] [Related]
18. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
Kamada T; Kaneko M; Tomioka H
Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients.
Sakurai K; Chubachi S; Irie H; Tsutsumi A; Kameyama N; Kamatani T; Koh H; Terashima T; Nakamura H; Asano K; Betsuyaku T
BMC Pulm Med; 2018 May; 18(1):65. PubMed ID: 29720140
[TBL] [Abstract][Full Text] [Related]
20. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]